Danoval and omnadren effect on the patients with dysfunctional uterine bleedings during the premenopause

E. G. Gumenyuk , L. A. Samorodinova

Journal of obstetrics and women's diseases ›› 1999, Vol. 48 ›› Issue (1) : 20 -24.

PDF
Journal of obstetrics and women's diseases ›› 1999, Vol. 48 ›› Issue (1) : 20 -24. DOI: 10.17816/JOWD87965
Original study articles
research-article

Danoval and omnadren effect on the patients with dysfunctional uterine bleedings during the premenopause

Author information +
History +
PDF

Abstract

Initial level of gonadothropic, steroid hormones in the blood, receptors of estradiol and progesteron of the endometrium in the patients with dysfunctional uterine bleedings during the premenopause, and their dunamics during and after hormone therapy were studied.

Danoval and oxy prog esterone-capronat in combination with omnadren had different effect on the parameters of the hormonal homeostasis and receptor apparatus of the endometrium. Antigonadоthropic effect of danoval results in FSG level reduction, estradiol and progesterone decrease in the blood and that of steroid receptors in the endometrium, that did not take place with other therapies. The effectiveness of the treatment with danoval was 88,24%, and it was 62,50% when oxy prog esterone-capronat with omnadren therapy was used.

It is concluded that danoval prescription to the patients with dysfunctional uterine bleedings during the menopause is more expedient for the wide spectrum of antigonadothropic effect.

Keywords

danoval / omnadren / premenopause / uterine bleeding / estradiol / progesterone

Cite this article

Download citation ▾
E. G. Gumenyuk, L. A. Samorodinova. Danoval and omnadren effect on the patients with dysfunctional uterine bleedings during the premenopause. Journal of obstetrics and women's diseases, 1999, 48(1): 20-24 DOI:10.17816/JOWD87965

登录浏览全文

4963

注册一个新账户 忘记密码

References

[1]

Адамян Л.В., Фанченко Н.Д., Анашкина Г.А., Стрижаков А.Н. Лечение даназолом распространенных форм эндометриоза //Акуш. и тин. -1988. - № 3. ??С. 63 - 64.

[2]

Вихляева Е.М. Фармакология репродуктивной системы женщины: клиническое применение агонистов и антагонистов половых гормонов в гинекологической практике // Materia medica -1994. -№ 4. -С.5-19.

[3]

Вихляева Е.М., Уварова Е.В., Ищенко И.Г. Опыт применения даназола у больных с сочетанной патологией эндо- и миометрия // Акуш. и гин. -1995. ??№ 1. -С. 41-44.

[4]

Вихляева Е.М., Ищенко И.Г., Ходжаева З.С., Фанченко Н.Д. Клинический эффект неместрана и данатрола при перименопаузальных кровотечениях у больных лейомиомой матки //Акуш. и гин. - 1996. -№ 6. -С. 30-34.

[5]

Вихляева Е.М., Железнов Б.Ю., Запорожан В.Н. Гиперпластические процессы эндометрия // Руководство по эндокринной гинекологии /Под ред. Е.М. Вихляевой. -М.: Медицинское информационное агентство. -1997. - С. 684-710.

[6]

Прилепская В.Н. Дисфункциональные маточные кровотечения климактерического периода //Акуш. и гин. -1993. -№ 6. - С. 9-14.

[7]

Сидорова И.С., Гуриев Т.Д. Даназол в лечении эндометриоза // Тер. архив. -1994. -Т. 66, № 10. -С. 55-57.

[8]

Тумилович Л.Г. Маточные кровотечения в пременопаузальном возрасте //Акуш. и гин. -1987. -№ 5 - С. 72-76.

[9]

Baldom A., Sarti D.С., Affronti G. et al. Metrorragia post-menopausale. L’uso del danazolo nella iperplasia endometriale //Minerva ginecol. - 1989. -Vol. 41, № 12.- P. 603-607.

[10]

Barbieri R.L. Comparison of the pharmacology of nafarelin and danazol //Am. J. Obstet. Gynecol. -1990. -Vol. 162, №2. -P. 581-585.

[11]

Garry R., Khair A., Mooney P, Stuart M. A comparison of goserelin and danazol as endometrial thinning agents prior to endometrial laser ablation //Br. J. Obstet. Gynaecol. - 1996. -Vol. 103, № 4. -P. 339-344.

[12]

Ikegami H., Terakawa N., ShimiziI. et al. Danazol binds to progesterone receptors and inhibits the growth of human endometrial cancer cells in vitro//Am. J. Obstet. Gynecol. -1986. - Vol. 155, № 4.-P. 857-861.

[13]

Mosse B., Lo Preaito A., Isidori C. et al. Esperienze preliminari sull’uso del Danazolo, a dosaggi minimi, nel trattamento delle menometrorragie disfunzionali //Minerva ginecol. 1987. -Vol. 39, № 11. -P. 801-803.

[14]

Murakami K., Nakagawa T., Yamashiro G. et al. Levels of androgens and danazol metabolites in serum during danazol therapy //Fertil. Steril. -1993. -Vol. 60, № 1.-P. 179- 182.

[15]

Negami A.I., Sasaki H., Tominaga T. Therapeutic effects of danazol on endometrial cells may be activated by the presence of extracellular matrix// Am. J. Obstet. Gynecol. -1993. -Vol. 169, № 3. -P. 739-744.

[16]

Rose G.L., Dowsett M., Mudge J.R. et al. The inhibitory effects of danazol, danazol metabolites, gestrinon, and testosterone on the growth of human endometrial cells in vitro //Fertil. Steril. -1988.-Vol. 49. -P. 224-228.

[17]

Surrey E.S., Halme J. Direct effects of medroxyprogesterone acetate, danazol and endometrial stromal cells proliferation in vitro //Fertil. Steril. - 1992. -Vol. 58, N° 2.-P. 273-279.

[18]

Yamashita S., Ohno Y., Watanaba Y. et al. Antiestrogenic effects of danazol on rabbit uterus //Gynecol. Obstet. Invest. -1994. -Vol. 38, №4. - P. 245-248.

RIGHTS & PERMISSIONS

Eсо-Vector

AI Summary AI Mindmap
PDF

127

Accesses

0

Citation

Detail

Sections
Recommended

AI思维导图

/